Review



human tumour necrosis factor alpha  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    R&D Systems human tumour necrosis factor alpha
    Human Tumour Necrosis Factor Alpha, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 829 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tumour+necrosis+factor+alpha/Human+TNF-alpha+DuoSet+ELISA/pmc12926579-106-0-25
    Average 97 stars, based on 829 article reviews
    human tumour necrosis factor alpha - by Bioz Stars, 2026-10
    97/100 stars

    Images

    Related Articles

    Negative Control:

    Article Title: Immunoglobulins G from Patients with Systemic Sclerosis Modify the Molecular Signatures of Endothelial Cells.
    Article Snippet: .. Three positive controls were set in quadruplicate: EC stimulated by interleukin- 1 beta (IL- 1β, 2 ng/ mL, 240- B, R&D systems, Minneapolis, Minnesota, USA), tumour necrosis factor alpha (TNF-α, 2 ng/mL, 210- TA, R&D systems, Minneapolis, Minnesota, USA) or lipopolysaccharide (LPS, Escherichia coli O127:B8, Sigma- Aldrich, Saint- Louis, Missouri, USA); the negative control was constituted by non- stimulated EC (pentaplicate). ..

    Article Title: Immunoglobulins G from Patients with Systemic Sclerosis Modify the Molecular Signatures of Endothelial Cells
    Article Snippet: .. Three positive controls were set in quadruplicate: EC stimulated by interleukin-1 beta (IL-1β, 2 ng/mL, 240-B, R&D systems, Minneapolis, Minnesota, USA), tumour necrosis factor alpha (TNF-α, 2 ng/mL, 210-TA, R&D systems, Minneapolis, Minnesota, USA) or lipopolysaccharide (LPS, Escherichia coli O127:B8, Sigma-Aldrich, Saint-Louis, Missouri, USA); the negative control was constituted by non-stimulated EC (pentaplicate). ..

    Recombinant:

    Article Title: IL-13 decreases susceptibility to airway epithelial SARS-CoV-2 infection but increases disease severity in vivo via eicosanoid signalling.
    Article Snippet: .. Cell cultures were treated with 20 ng/mL recombinant IL-13 (R&D Systems, 213-ILB-100/CF) or 20 ng/mL recombinant IL-17 (R&D Systems, 210-TA) combined with 10 ng/mL tumour necrosis factor alpha (TNFα, R&D Systems, 317-ILB-050) for 4 or 55 days. ..

    Article Title: Tonic repression of collagen I by the bradykinin receptor 2 in skin fibroblasts.
    Article Snippet: .. Recombinant human TGF-b1 (#100-B) and tumour necrosis factor alpha (#210-TA) were purchased from R&D Systems Inc (Minneapolis, MN) and reconstituted in 4 mM HCl containing 1% bovine serum albumin. .. HOE-140 was purchased from Sigma Aldrich (H-157) and PD98059 and FR180204 were purchased from Tocris. siRNAs, transfection and RNAi screening Control siRNA, ON-TARGET plus non-targeting siRNA (#D-001810-01), GFP (#P-002048-01) and other siRNA duplexes targeting GOLGB1 (Giantin) (#M-019809-01-0005), Smad2 (#M-003561-010005), Smad3 (#M-020067-00-0005), MAPK1 (#M003555-04-0005), MAPK3 (#M-003592-03-0005) were purchased from Dharmacon.

    Article Title: IL-13 decreases susceptibility to airway epithelial SARS-CoV-2 infection but increases disease severity in vivo via eicosanoid signalling
    Article Snippet: .. Cell cultures were treated with 20 ng/mL recombinant IL-13 (R&D Systems, 213-ILB-100/CF) or 20 ng/mL recombinant IL-17 (R&D Systems, 210-TA) combined with 10 ng/mL tumour necrosis factor alpha (TNFα, R&D Systems, 317-ILB-050) for 4 or 55 days. ..

    Incubation:

    Article Title: Endopeptidase O promotes Streptococcus suis immune evasion by cleaving the host- defence peptide cathelicidins
    Article Snippet: .. Freshly collected mouse neutrophils (1 × 10 6 cells) were incubated with 1 μM of LL-37, mCRAMP, the proteolytic products LL-37/PepO and mCRAMP/PepO, and the truncated peptides at 37°C for 30 min. Then, apoptosis was induced at 37°C for 6 hours using 30 ng/ml of tumour necrosis factor-alpha (TNF-α, R&D systems, 210-TA-020). ..

    Article Title: Endopeptidase O promotes Streptococcus suis immune evasion by cleaving the host- defence peptide cathelicidins.
    Article Snippet: .. Freshly collected mouse neutrophils (1 × 106 cells) were incubated with 1 μM of LL-37, mCRAMP, the proteolytic products LL-37/PepO and mCRAMP/PepO, and the truncated peptides at 37°C for 30 min. Then, apoptosis was induced at 37°C for 6 hours using 30 ng/ml of tumour necrosis factor-alpha (TNF-α, R&D systems, 210-TA-020). ..

    Enzyme-linked Immunosorbent Assay:

    Article Title: Combined resistance exercise and essential amino acid intake enhance follistatin/myostatin ratio and muscle fitness in older women: a randomized controlled trial
    Article Snippet: .. Serum concentrations of fasting insulin (440132, Beckman Coulter, California, CA, USA), serum levels of myokine biomarkers including IL-15, irisin, myostatin, and follistatin (DY247, DY9420-05, DY788-05, and DY669: R&D Systems, Minneapolis, MN, USA), and inflammatory cytokine biomarkers such as IL-1β, IL-6, and tumour necrosis factor-alpha (TNF- α ) (DY201, DY206, and DY210: R&D Systems, Minneapolis, MN, USA) were measured using DuoSet TM enzyme-linked immunosorbent assay (ELISA) kits (R&D Systems, Minneapolis, MN, USA) in accordance with the manufacturer’s instructions. ..



    Similar Products

    98
    Thermo Fisher tumour necrosis factor alpha tnfα
    Tumour Necrosis Factor Alpha Tnfα, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tumour+necrosis+factor+alpha/Tumor+Necrosis+Factor-alpha%2C+human/10__3390_slash_scipharm94020047-75-2-20
    Average 98 stars, based on 1 article reviews
    tumour necrosis factor alpha tnfα - by Bioz Stars, 2026-10
    98/100 stars
      Buy from Supplier

    96
    MedChemExpress tumour necrosis factor alpha tnf α
    Tumour Necrosis Factor Alpha Tnf α, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tumour+necrosis+factor+alpha/TNF-alpha%2FTNFSF2%2C+Human/pmc13370715-99-33-38
    Average 96 stars, based on 1 article reviews
    tumour necrosis factor alpha tnf α - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    94
    RayBiotech inc tumour necrosis factor α
    Tumour Necrosis Factor α, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tumour+necrosis+factor+alpha/Rat+TNF-alpha+ELISA/pm42611145-42-3-13
    Average 94 stars, based on 1 article reviews
    tumour necrosis factor α - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    91
    RayBiotech inc recombinant human tumour necrosis factor alpha tnfα
    ( A ) Schematic overview of <t>TNFα/TNFR1</t> signalling. Engagement of TNFR1 promotes formation of membrane-associated complex I, leading to activation of NF-κB and MAPK signalling pathways and induction of pro-survival gene expression. Disruption of this pathway can result in formation of cytosolic complex IIa, leading to caspase activation and apoptosis. Birinapant promotes degradation of cIAP1/2, destabilising complex I and favouring early complex II formation, whereas cycloheximide inhibits protein synthesis and prevents accumulation of pro-survival factors downstream of TNFR1 signalling. ( B ) Quantification of live cells following treatment with TNFα, birinapant, or their combination (BT), assessed by flow cytometry in MDA-MB-231 cells. Cells were stained with Annexin V and propidium iodide (PI), and live cells were defined as Annexin V-negative/PI-negative. Data represent mean ± SD from three independent biological replicates. ( C ) Time-resolved analysis of cell viability following treatment with TNFα in combination with birinapant ( left ) or cycloheximide ( right ). Live-cell percentages were quantified from IncuCyte live-cell imaging using FluoroFate. BT treatment induces rapid and near-complete loss of viability, whereas CT treatment results in delayed but progressive cell death, demonstrating distinct temporal dynamics depending on the mode of TNFα pathway perturbation. ( D ) Representative live-cell imaging of MDA-MB-231 cells over the first 6 hours following treatment with untreated control (UT), BT, or CT. Annexin V-positive cells (green) and PI-positive cells (red) are shown overlaid on brightfield images. BT treatment results in rapid and widespread Annexin V staining, whereas CT treatment shows delayed onset of cell death. Scale bar, 100 μm. [ E ] Flow cytometry analysis of Annexin V staining over the first 6 hours following BT treatment. Representative dot plots show progressive increase in Annexin V-positive cells over time, confirming rapid induction of apoptosis at the single-cell level. Statistical significance was determined using one-way ANOVA with Dunnett’s post-hoc test, with **** indicating P < 0.0001 and ns indicating non-significant differences.
    Recombinant Human Tumour Necrosis Factor Alpha Tnfα, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tumour+necrosis+factor+alpha/Tumor+Necrosis+Factor-Alpha%2C+Human+Recombinant/bio_rxiv__64898__2026__08__17__745187-122-0-10
    Average 91 stars, based on 1 article reviews
    recombinant human tumour necrosis factor alpha tnfα - by Bioz Stars, 2026-10
    91/100 stars
      Buy from Supplier

    97
    R&D Systems human tumour necrosis factor alpha
    ( A ) Schematic overview of <t>TNFα/TNFR1</t> signalling. Engagement of TNFR1 promotes formation of membrane-associated complex I, leading to activation of NF-κB and MAPK signalling pathways and induction of pro-survival gene expression. Disruption of this pathway can result in formation of cytosolic complex IIa, leading to caspase activation and apoptosis. Birinapant promotes degradation of cIAP1/2, destabilising complex I and favouring early complex II formation, whereas cycloheximide inhibits protein synthesis and prevents accumulation of pro-survival factors downstream of TNFR1 signalling. ( B ) Quantification of live cells following treatment with TNFα, birinapant, or their combination (BT), assessed by flow cytometry in MDA-MB-231 cells. Cells were stained with Annexin V and propidium iodide (PI), and live cells were defined as Annexin V-negative/PI-negative. Data represent mean ± SD from three independent biological replicates. ( C ) Time-resolved analysis of cell viability following treatment with TNFα in combination with birinapant ( left ) or cycloheximide ( right ). Live-cell percentages were quantified from IncuCyte live-cell imaging using FluoroFate. BT treatment induces rapid and near-complete loss of viability, whereas CT treatment results in delayed but progressive cell death, demonstrating distinct temporal dynamics depending on the mode of TNFα pathway perturbation. ( D ) Representative live-cell imaging of MDA-MB-231 cells over the first 6 hours following treatment with untreated control (UT), BT, or CT. Annexin V-positive cells (green) and PI-positive cells (red) are shown overlaid on brightfield images. BT treatment results in rapid and widespread Annexin V staining, whereas CT treatment shows delayed onset of cell death. Scale bar, 100 μm. [ E ] Flow cytometry analysis of Annexin V staining over the first 6 hours following BT treatment. Representative dot plots show progressive increase in Annexin V-positive cells over time, confirming rapid induction of apoptosis at the single-cell level. Statistical significance was determined using one-way ANOVA with Dunnett’s post-hoc test, with **** indicating P < 0.0001 and ns indicating non-significant differences.
    Human Tumour Necrosis Factor Alpha, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tumour+necrosis+factor+alpha/Human+TNF-alpha+DuoSet+ELISA/pmc12926579-106-0-25
    Average 97 stars, based on 1 article reviews
    human tumour necrosis factor alpha - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    98
    Thermo Fisher tumour necrosis factor α tnf α
    ( A ) Schematic overview of <t>TNFα/TNFR1</t> signalling. Engagement of TNFR1 promotes formation of membrane-associated complex I, leading to activation of NF-κB and MAPK signalling pathways and induction of pro-survival gene expression. Disruption of this pathway can result in formation of cytosolic complex IIa, leading to caspase activation and apoptosis. Birinapant promotes degradation of cIAP1/2, destabilising complex I and favouring early complex II formation, whereas cycloheximide inhibits protein synthesis and prevents accumulation of pro-survival factors downstream of TNFR1 signalling. ( B ) Quantification of live cells following treatment with TNFα, birinapant, or their combination (BT), assessed by flow cytometry in MDA-MB-231 cells. Cells were stained with Annexin V and propidium iodide (PI), and live cells were defined as Annexin V-negative/PI-negative. Data represent mean ± SD from three independent biological replicates. ( C ) Time-resolved analysis of cell viability following treatment with TNFα in combination with birinapant ( left ) or cycloheximide ( right ). Live-cell percentages were quantified from IncuCyte live-cell imaging using FluoroFate. BT treatment induces rapid and near-complete loss of viability, whereas CT treatment results in delayed but progressive cell death, demonstrating distinct temporal dynamics depending on the mode of TNFα pathway perturbation. ( D ) Representative live-cell imaging of MDA-MB-231 cells over the first 6 hours following treatment with untreated control (UT), BT, or CT. Annexin V-positive cells (green) and PI-positive cells (red) are shown overlaid on brightfield images. BT treatment results in rapid and widespread Annexin V staining, whereas CT treatment shows delayed onset of cell death. Scale bar, 100 μm. [ E ] Flow cytometry analysis of Annexin V staining over the first 6 hours following BT treatment. Representative dot plots show progressive increase in Annexin V-positive cells over time, confirming rapid induction of apoptosis at the single-cell level. Statistical significance was determined using one-way ANOVA with Dunnett’s post-hoc test, with **** indicating P < 0.0001 and ns indicating non-significant differences.
    Tumour Necrosis Factor α Tnf α, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tumour+necrosis+factor+alpha/Tumor+Necrosis+Factor-alpha%2C+human/pm42347404-104-9-23
    Average 98 stars, based on 1 article reviews
    tumour necrosis factor α tnf α - by Bioz Stars, 2026-10
    98/100 stars
      Buy from Supplier

    97
    ABclonal Biotechnology tumour necrosis actor alpha
    ( A ) Schematic overview of <t>TNFα/TNFR1</t> signalling. Engagement of TNFR1 promotes formation of membrane-associated complex I, leading to activation of NF-κB and MAPK signalling pathways and induction of pro-survival gene expression. Disruption of this pathway can result in formation of cytosolic complex IIa, leading to caspase activation and apoptosis. Birinapant promotes degradation of cIAP1/2, destabilising complex I and favouring early complex II formation, whereas cycloheximide inhibits protein synthesis and prevents accumulation of pro-survival factors downstream of TNFR1 signalling. ( B ) Quantification of live cells following treatment with TNFα, birinapant, or their combination (BT), assessed by flow cytometry in MDA-MB-231 cells. Cells were stained with Annexin V and propidium iodide (PI), and live cells were defined as Annexin V-negative/PI-negative. Data represent mean ± SD from three independent biological replicates. ( C ) Time-resolved analysis of cell viability following treatment with TNFα in combination with birinapant ( left ) or cycloheximide ( right ). Live-cell percentages were quantified from IncuCyte live-cell imaging using FluoroFate. BT treatment induces rapid and near-complete loss of viability, whereas CT treatment results in delayed but progressive cell death, demonstrating distinct temporal dynamics depending on the mode of TNFα pathway perturbation. ( D ) Representative live-cell imaging of MDA-MB-231 cells over the first 6 hours following treatment with untreated control (UT), BT, or CT. Annexin V-positive cells (green) and PI-positive cells (red) are shown overlaid on brightfield images. BT treatment results in rapid and widespread Annexin V staining, whereas CT treatment shows delayed onset of cell death. Scale bar, 100 μm. [ E ] Flow cytometry analysis of Annexin V staining over the first 6 hours following BT treatment. Representative dot plots show progressive increase in Annexin V-positive cells over time, confirming rapid induction of apoptosis at the single-cell level. Statistical significance was determined using one-way ANOVA with Dunnett’s post-hoc test, with **** indicating P < 0.0001 and ns indicating non-significant differences.
    Tumour Necrosis Actor Alpha, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tumour+necrosis+factor+alpha/Mouse+Tumor+Necrosis+Factor+Alpha+ELISA+Kit/pm42338032-97-21-26
    Average 97 stars, based on 1 article reviews
    tumour necrosis actor alpha - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    98
    Thermo Fisher tumour necrosis factor alpha tnf α
    Aedes aegypti salivary gland extract (SGE) modulates cytokine production by antigen-presenting cell lines during Zika virus (ZIKV) infection. JAWS II dendritic cells and RAW 264.7 macrophages were cultured for 72 h under the indicated conditions (Only Media, SGE, ZIKV, or ZIKV+SGE at different concentrations). Cytokine concentrations [tumour necrosis <t>factor-alpha</t> <t>(TNF-α),</t> interleukin-1beta (IL-1β), IL-10, IL-12] were quantified in culture supernatants by enzyme-linked immunosorbent assay (ELISA). In JAWS II cells (A-D), significant differences were observed <t>for</t> <t>TNF-α,</t> IL-1β, and IL-12, while IL-10 levels remained stable. In RAW 264.7 cells (E-H), SGE <t>enhanced</t> <t>TNF-α,</t> IL-1β, and IL-10 secretion, whereas IL-12 showed no significant modulation. Data represent individual values from independent experiments with bars indicating mean ± standard error of the mean (SEM). Statistical analysis was performed using Kruskal-Wallis with Dunn’s post-hoc test; p < 0.05 was considered significant.
    Tumour Necrosis Factor Alpha Tnf α, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tumour+necrosis+factor+alpha/Tumor+Necrosis+Factor-alpha%2C+human/pmc13143171-77-14-31
    Average 98 stars, based on 1 article reviews
    tumour necrosis factor alpha tnf α - by Bioz Stars, 2026-10
    98/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Schematic overview of TNFα/TNFR1 signalling. Engagement of TNFR1 promotes formation of membrane-associated complex I, leading to activation of NF-κB and MAPK signalling pathways and induction of pro-survival gene expression. Disruption of this pathway can result in formation of cytosolic complex IIa, leading to caspase activation and apoptosis. Birinapant promotes degradation of cIAP1/2, destabilising complex I and favouring early complex II formation, whereas cycloheximide inhibits protein synthesis and prevents accumulation of pro-survival factors downstream of TNFR1 signalling. ( B ) Quantification of live cells following treatment with TNFα, birinapant, or their combination (BT), assessed by flow cytometry in MDA-MB-231 cells. Cells were stained with Annexin V and propidium iodide (PI), and live cells were defined as Annexin V-negative/PI-negative. Data represent mean ± SD from three independent biological replicates. ( C ) Time-resolved analysis of cell viability following treatment with TNFα in combination with birinapant ( left ) or cycloheximide ( right ). Live-cell percentages were quantified from IncuCyte live-cell imaging using FluoroFate. BT treatment induces rapid and near-complete loss of viability, whereas CT treatment results in delayed but progressive cell death, demonstrating distinct temporal dynamics depending on the mode of TNFα pathway perturbation. ( D ) Representative live-cell imaging of MDA-MB-231 cells over the first 6 hours following treatment with untreated control (UT), BT, or CT. Annexin V-positive cells (green) and PI-positive cells (red) are shown overlaid on brightfield images. BT treatment results in rapid and widespread Annexin V staining, whereas CT treatment shows delayed onset of cell death. Scale bar, 100 μm. [ E ] Flow cytometry analysis of Annexin V staining over the first 6 hours following BT treatment. Representative dot plots show progressive increase in Annexin V-positive cells over time, confirming rapid induction of apoptosis at the single-cell level. Statistical significance was determined using one-way ANOVA with Dunnett’s post-hoc test, with **** indicating P < 0.0001 and ns indicating non-significant differences.

    Journal: bioRxiv

    Article Title: FluoroFate: A generalisable platform for time-resolved single-cell analysis of cell fate enables quantification of cell death dynamics

    doi: 10.64898/2026.08.17.745187

    Figure Lengend Snippet: ( A ) Schematic overview of TNFα/TNFR1 signalling. Engagement of TNFR1 promotes formation of membrane-associated complex I, leading to activation of NF-κB and MAPK signalling pathways and induction of pro-survival gene expression. Disruption of this pathway can result in formation of cytosolic complex IIa, leading to caspase activation and apoptosis. Birinapant promotes degradation of cIAP1/2, destabilising complex I and favouring early complex II formation, whereas cycloheximide inhibits protein synthesis and prevents accumulation of pro-survival factors downstream of TNFR1 signalling. ( B ) Quantification of live cells following treatment with TNFα, birinapant, or their combination (BT), assessed by flow cytometry in MDA-MB-231 cells. Cells were stained with Annexin V and propidium iodide (PI), and live cells were defined as Annexin V-negative/PI-negative. Data represent mean ± SD from three independent biological replicates. ( C ) Time-resolved analysis of cell viability following treatment with TNFα in combination with birinapant ( left ) or cycloheximide ( right ). Live-cell percentages were quantified from IncuCyte live-cell imaging using FluoroFate. BT treatment induces rapid and near-complete loss of viability, whereas CT treatment results in delayed but progressive cell death, demonstrating distinct temporal dynamics depending on the mode of TNFα pathway perturbation. ( D ) Representative live-cell imaging of MDA-MB-231 cells over the first 6 hours following treatment with untreated control (UT), BT, or CT. Annexin V-positive cells (green) and PI-positive cells (red) are shown overlaid on brightfield images. BT treatment results in rapid and widespread Annexin V staining, whereas CT treatment shows delayed onset of cell death. Scale bar, 100 μm. [ E ] Flow cytometry analysis of Annexin V staining over the first 6 hours following BT treatment. Representative dot plots show progressive increase in Annexin V-positive cells over time, confirming rapid induction of apoptosis at the single-cell level. Statistical significance was determined using one-way ANOVA with Dunnett’s post-hoc test, with **** indicating P < 0.0001 and ns indicating non-significant differences.

    Article Snippet: Recombinant human tumour necrosis factor alpha (TNFα) was obtained from RayBiotech, birinapant from Apexbio, cycloheximide from Cell Signaling Technology, Annexin V-FITC from Biotium, and propidium iodide from Abcam.

    Techniques: Membrane, Activation Assay, Gene Expression, Disruption, Flow Cytometry, Staining, Live Cell Imaging, Control, Single Cell

    ( A ) Schematic overview of TNFα/TNFR1 signalling, illustrating that disruption of complex IIa can promote formation of cytosolic complex IIb, from which signalling through RIPK1/RIPK3/MLKL can drive non-apoptotic cell death. ( B ) Western blot analysis of apoptotic signalling following BT treatment in MDA-MB-231 cells over the indicated time course. Cleavage of PARP, caspase 3, and caspase 8 confirms induction of apoptosis. Autophosphorylation of RIPK1 (p-RIPK1) at Ser166 and reduction of cIAP1 levels demonstrate modulation of TNFα/TNFR1 signalling. Β-actin serves as a loading control. ( C ) FluoroFate analysis of cell death dynamics in MDA-MB-231 cells following treatment with BT ( left ) or CT ( right ). The proportion of cells undergoing apoptosis (Annexin V-positive prior to PI), non-apoptotic cell death (PI-positive prior to or concurrent with Annexin V), and total cell death is shown. BT induces rapid and predominantly apoptotic cell death, whereas CT results in delayed and more heterogeneous cell death dynamics. ( D ) Quantification of live cells in SKOV3 WT and RIPK1 KO cells following BT treatment, assessed by flow cytometry. Cells were stained with Annexin V-FITC and PI, and live cells were defined as Annexin V-negative/PI-negative. RIPK1 KO cells exhibit increased resistance to BT-induced cell death compared to WT cells. [ E ] FluoroFate analysis of cell viability in SKOV3 WT and RIPK1 KO cells following BT treatment. Loss of RIPK1 delays and reduces overall cell death kinetics. ( F ) Single-cell classification of apoptotic and non-apoptotic cell death in SKOV3 WT ( left ) and RIPK1 KO ( right ) cells following BT treatment. Loss of RIPK1 selectively reduces apoptotic cell death, whilst non-apoptotic cell death remains largely unchanged, indicating that distinct modes of cell death are independently regulated at the single-cell level. Data represent mean ± SD from three biological replicates. Statistical significance was determined using two-way ANOVA followed by Fisher’s LSD post-hoc test (***P ≤ 0.0002, ****P < 0.0001, ns, not significant).

    Journal: bioRxiv

    Article Title: FluoroFate: A generalisable platform for time-resolved single-cell analysis of cell fate enables quantification of cell death dynamics

    doi: 10.64898/2026.08.17.745187

    Figure Lengend Snippet: ( A ) Schematic overview of TNFα/TNFR1 signalling, illustrating that disruption of complex IIa can promote formation of cytosolic complex IIb, from which signalling through RIPK1/RIPK3/MLKL can drive non-apoptotic cell death. ( B ) Western blot analysis of apoptotic signalling following BT treatment in MDA-MB-231 cells over the indicated time course. Cleavage of PARP, caspase 3, and caspase 8 confirms induction of apoptosis. Autophosphorylation of RIPK1 (p-RIPK1) at Ser166 and reduction of cIAP1 levels demonstrate modulation of TNFα/TNFR1 signalling. Β-actin serves as a loading control. ( C ) FluoroFate analysis of cell death dynamics in MDA-MB-231 cells following treatment with BT ( left ) or CT ( right ). The proportion of cells undergoing apoptosis (Annexin V-positive prior to PI), non-apoptotic cell death (PI-positive prior to or concurrent with Annexin V), and total cell death is shown. BT induces rapid and predominantly apoptotic cell death, whereas CT results in delayed and more heterogeneous cell death dynamics. ( D ) Quantification of live cells in SKOV3 WT and RIPK1 KO cells following BT treatment, assessed by flow cytometry. Cells were stained with Annexin V-FITC and PI, and live cells were defined as Annexin V-negative/PI-negative. RIPK1 KO cells exhibit increased resistance to BT-induced cell death compared to WT cells. [ E ] FluoroFate analysis of cell viability in SKOV3 WT and RIPK1 KO cells following BT treatment. Loss of RIPK1 delays and reduces overall cell death kinetics. ( F ) Single-cell classification of apoptotic and non-apoptotic cell death in SKOV3 WT ( left ) and RIPK1 KO ( right ) cells following BT treatment. Loss of RIPK1 selectively reduces apoptotic cell death, whilst non-apoptotic cell death remains largely unchanged, indicating that distinct modes of cell death are independently regulated at the single-cell level. Data represent mean ± SD from three biological replicates. Statistical significance was determined using two-way ANOVA followed by Fisher’s LSD post-hoc test (***P ≤ 0.0002, ****P < 0.0001, ns, not significant).

    Article Snippet: Recombinant human tumour necrosis factor alpha (TNFα) was obtained from RayBiotech, birinapant from Apexbio, cycloheximide from Cell Signaling Technology, Annexin V-FITC from Biotium, and propidium iodide from Abcam.

    Techniques: Disruption, Western Blot, Control, Flow Cytometry, Staining, Single Cell

    Aedes aegypti salivary gland extract (SGE) modulates cytokine production by antigen-presenting cell lines during Zika virus (ZIKV) infection. JAWS II dendritic cells and RAW 264.7 macrophages were cultured for 72 h under the indicated conditions (Only Media, SGE, ZIKV, or ZIKV+SGE at different concentrations). Cytokine concentrations [tumour necrosis factor-alpha (TNF-α), interleukin-1beta (IL-1β), IL-10, IL-12] were quantified in culture supernatants by enzyme-linked immunosorbent assay (ELISA). In JAWS II cells (A-D), significant differences were observed for TNF-α, IL-1β, and IL-12, while IL-10 levels remained stable. In RAW 264.7 cells (E-H), SGE enhanced TNF-α, IL-1β, and IL-10 secretion, whereas IL-12 showed no significant modulation. Data represent individual values from independent experiments with bars indicating mean ± standard error of the mean (SEM). Statistical analysis was performed using Kruskal-Wallis with Dunn’s post-hoc test; p < 0.05 was considered significant.

    Journal: Memórias do Instituto Oswaldo Cruz

    Article Title: Aedes aegypti salivary gland extract enhances Zika virus replication through immune modulation

    doi: 10.1590/0074-02760250272

    Figure Lengend Snippet: Aedes aegypti salivary gland extract (SGE) modulates cytokine production by antigen-presenting cell lines during Zika virus (ZIKV) infection. JAWS II dendritic cells and RAW 264.7 macrophages were cultured for 72 h under the indicated conditions (Only Media, SGE, ZIKV, or ZIKV+SGE at different concentrations). Cytokine concentrations [tumour necrosis factor-alpha (TNF-α), interleukin-1beta (IL-1β), IL-10, IL-12] were quantified in culture supernatants by enzyme-linked immunosorbent assay (ELISA). In JAWS II cells (A-D), significant differences were observed for TNF-α, IL-1β, and IL-12, while IL-10 levels remained stable. In RAW 264.7 cells (E-H), SGE enhanced TNF-α, IL-1β, and IL-10 secretion, whereas IL-12 showed no significant modulation. Data represent individual values from independent experiments with bars indicating mean ± standard error of the mean (SEM). Statistical analysis was performed using Kruskal-Wallis with Dunn’s post-hoc test; p < 0.05 was considered significant.

    Article Snippet: The supernatants were separated after 72 h of infection and used to quantify IL-1β, tumour necrosis factor-alpha (TNF-α), IL-12, and IL-10 using commercial enzyme-linked immunosorbent assay (ELISA) following the manufacturer’s instructions (Thermo Fisher).

    Techniques: Virus, Infection, Cell Culture, Enzyme-linked Immunosorbent Assay